Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion

Area of Science:

• Platelet biology
• Signal transduction
• Molecular mechanisms of secretion

Background:

• Protein kinase C-delta (PKC-delta) is involved in platelet activation.
• PKC-delta differentially regulates dense granule secretion downstream of protease-activated receptors (PARs) and glycoprotein VI (GPVI) receptors.
• The precise mechanisms underlying this differential regulation are not fully understood.

Purpose of the Study:

• To elucidate the mechanism by which PKC-delta differentially regulates dense granule release.
• To investigate the role of SH2 domain-containing inositol phosphatase-1 (SHIP-1) and Lyn kinase in PKC-delta-mediated platelet secretion.

Main Methods:

• Platelet stimulation with PAR and GPVI agonists.
• Western blotting to detect protein phosphorylation (SHIP-1 Y1020, PKC-delta Y311).
• Co-immunoprecipitation to assess protein-protein interactions (PKC-delta, Lyn, SHIP-1).
• Studies using knockout murine platelets (PKC-delta-null, Lyn-null).

Main Results:

• GPVI-mediated SHIP-1 phosphorylation at Y1020 was rapid, while PAR-mediated phosphorylation was delayed.
• Lyn and SHIP-1, but not SHIP-2 or Shc, associated with PKC-delta upon GPVI stimulation.
• PKC-delta-null platelets showed inhibited convulxin-induced SHIP-1 phosphorylation.
• Lyn-null platelets exhibited inhibited GPVI-mediated phosphorylation of SHIP-1 and PKC-delta.
• Absence of Lyn or SHIP-1 potentiated GPVI-mediated dense granule secretion but inhibited PAR-mediated secretion.

Conclusions:

• Lyn-mediated phosphorylation of PKC-delta and SHIP-1, and their association, negatively regulate GPVI-mediated dense granule secretion.
• This study reveals a novel regulatory pathway involving Lyn, PKC-delta, and SHIP-1 in platelet granule release.